Lead sponsor
University of Copenhagen
6 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
6
Trials led
2
Ongoing
160
Total enrollment
4
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Not applicable
5
Trials by status
Not yet recruiting
1
Recruiting
1
Completed
3
Unknown
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic MutationsBMI ≥28Ph 2Completed50